NORTHERN TRUST CORP - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$41,417
+64.2%
11,5690.0%0.00%
Q1 2023$25,221
-82.3%
11,569
-2.2%
0.00%
Q4 2022$142,339
+58.2%
11,832
-15.0%
0.00%
Q3 2022$90,000
+45.2%
13,925
+2.1%
0.00%
Q2 2022$62,000
-97.5%
13,640
-95.2%
0.00%
Q1 2022$2,443,000
-29.6%
282,378
+16.1%
0.00%
-100.0%
Q4 2021$3,472,000
-30.1%
243,125
+7.7%
0.00%0.0%
Q3 2021$4,964,000
+75.8%
225,831
+7.0%
0.00%
Q2 2021$2,824,000
+5034.5%
211,082
+1055.4%
0.00%
Q4 2018$55,000
-37.5%
18,269
+1.4%
0.00%
Q3 2018$88,00018,0100.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 366,401$2,374,0002.07%
Private Portfolio Partners LLC 67,400$436,7520.12%
Knoll Capital Management, LLC 20,000$130,0000.08%
ETF MANAGERS GROUP, LLC 94,493$612,0000.02%
Virtu Financial LLC 21,526$139,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 21,904$142,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$36,0000.01%
Walleye Capital LLC 78,418$508,0000.01%
Jump Financial, LLC 36,100$234,0000.01%
Plante Moran Financial Advisors, LLC 7,911$51,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders